Skip to main content

Johnson & Johnson to Participate in the Goldman Sachs 44th Annual Global Healthcare Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13th, at the Waldorf Astoria Monarch Beach Resort & Club in Dana Point, CA. Biljana Naumovic, Worldwide Vice President, Oncology, and Peter Lebowitz, Global Therapeutic Head, Oncology, will represent the Company in a session scheduled at 4:20 p.m. (Eastern Time).

This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

A webcast replay will be available approximately 48-hrs after the live webcast.

Recent Quotes

View More
Symbol Price Change (%)
AMZN  208.56
+3.29 (1.60%)
AAPL  272.14
+5.96 (2.24%)
AMD  213.84
+17.24 (8.77%)
BAC  50.41
-0.66 (-1.29%)
GOOG  310.92
-0.77 (-0.25%)
META  639.30
+2.05 (0.32%)
MSFT  389.00
+4.53 (1.18%)
NVDA  192.85
+1.30 (0.68%)
ORCL  146.14
+4.83 (3.42%)
TSLA  409.38
+9.55 (2.39%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.